{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T02:39:04Z","timestamp":1789871944939,"version":"4.0.1"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008209","name":"University at Buffalo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008209","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.clim.2017.04.003","type":"journal-article","created":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T04:48:25Z","timestamp":1491626905000},"page":"4-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"C","title":["Innate immunity in Sj\u00f6gren's syndrome"],"prefix":"10.1016","volume":"182","author":[{"given":"Jeremy","family":"Kiripolsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam G.","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9828-8556","authenticated-orcid":false,"given":"Jill M.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2017.04.003_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I","volume":"58","author":"Helmick","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.04.003_bb0010","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/acr.21610","article-title":"Primary Sjogren's syndrome as a systemic disease: a study of participants enrolled in an international Sjogren's syndrome registry","volume":"64","author":"Malladi","year":"2012","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.clim.2017.04.003_bb0015","first-page":"24","article-title":"Current concepts in Sjogren's syndrome and considerations for the dental practitioner","volume":"81","author":"Kramer","year":"2015","journal-title":"N. Y. Dent. J."},{"key":"10.1016\/j.clim.2017.04.003_bb0020","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/ar2210","article-title":"B cells in Sj\u00f6gren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue","volume":"9","author":"Hansen","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2017.04.003_bb0025","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/BOR.0000000000000195","article-title":"Update on the immunobiology of Sjogren's syndrome","volume":"27","author":"Ambrosi","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.clim.2017.04.003_bb0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-pathol-012513-104728","article-title":"Sjogren's syndrome","volume":"9","author":"Mavragani","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.clim.2017.04.003_bb0035","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-2249.2002.01869.x","article-title":"The Th1\/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome","volume":"128","author":"Mitsias","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0040","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12016-007-8011-8","article-title":"T lymphocytes in Sjogren's syndrome: contributors to and regulators of pathophysiology","volume":"32","author":"Katsifis","year":"2007","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0045","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium","volume":"111","author":"Ekstr\u00f6m Smedby","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clim.2017.04.003_bb0050","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/art.20276","article-title":"Abnormalities in peripheral B cell memory of patients with primary Sj\u00f6gren's syndrome","volume":"50","author":"Hansen","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.04.003_bb0055","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1365-3083.2003.01226.x","article-title":"Comparison of immunoglobulin heavy chain rearrangements between peripheral and glandular B cells in a patient with primary Sj\u00f6gren's syndrome","volume":"57","author":"Hansen","year":"2003","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0060","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2017.04.003_bb0065","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/cmi.2016.58","article-title":"Cellular and molecular regulation of innate inflammatory responses","volume":"13","author":"Liu","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0070","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0966-842X(00)01845-X","article-title":"The Toll receptor family and microbial recognition","volume":"8","author":"Medzhitov","year":"2000","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.clim.2017.04.003_bb0075","doi-asserted-by":"crossref","first-page":"24035","DOI":"10.1074\/jbc.M109.014266","article-title":"Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors","volume":"284","author":"Babelova","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2017.04.003_bb0080","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1172\/JCI42213","article-title":"The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis","volume":"120","author":"Moreth","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2017.04.003_bb0085","doi-asserted-by":"crossref","first-page":"232ra250","DOI":"10.1126\/scitranslmed.3008264","article-title":"FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling","volume":"6","author":"Bhattacharyya","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.clim.2017.04.003_bb0090","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nm.1987","article-title":"Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease","volume":"15","author":"Midwood","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2017.04.003_bb0095","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1073\/pnas.0510837103","article-title":"Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sj\u00f6gren's syndrome","volume":"103","author":"Gottenberg","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2017.04.003_bb0100","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","article-title":"Characteristics of the minor salivary gland infiltrates in Sj\u00f6gren's syndrome","volume":"34","author":"Christodoulou","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2017.04.003_bb0105","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.2792","article-title":"Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome","volume":"45","author":"Lessard","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2017.04.003_bb0110","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/ar3318","article-title":"Aspects of innate immunity in Sj\u00f6gren's syndrome","volume":"13","author":"Low","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2017.04.003_bb0115","doi-asserted-by":"crossref","first-page":"549107","DOI":"10.1155\/2011\/549107","article-title":"Current concepts: mouse models of Sj\u00f6gren's syndrome","volume":"2011","author":"Lavoie","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.clim.2017.04.003_bb0120","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1186\/ar2676","article-title":"Differential gene expression in the salivary gland during development and onset of xerostomia in Sj\u00f6gren's syndrome-like disease of the C57BL\/6.NOD-Aec1Aec2 mouse","volume":"11","author":"Nguyen","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2017.04.003_bb0125","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/labinvest.3700487","article-title":"Early pathogenic events associated with Sjogren's syndrome (SjS)-like disease of the NOD mouse using microarray analysis","volume":"86","author":"Killedar","year":"2006","journal-title":"Lab. Investig."},{"key":"10.1016\/j.clim.2017.04.003_bb0130","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.exer.2008.10.006","article-title":"Differential gene expressions in the lacrimal gland during development and onset of keratoconjunctivitis sicca in Sjogren's syndrome (SJS)-like disease of the C57BL\/6.NOD-Aec1Aec2 mouse","volume":"88","author":"Nguyen","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.clim.2017.04.003_bb0135","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2012.11.016","article-title":"Enhanced apoptosis by disruption of the STAT3-I\u03baB-\u03b6 signaling pathway in epithelial cells induces Sj\u00f6gren's syndrome-like autoimmune disease","volume":"38","author":"Okuma","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2017.04.003_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2012.01.008","article-title":"Genetics of Sj\u00f6gren's syndrome in the genome-wide association era","author":"Ice","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2017.04.003_bb0145","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.tripleo.2011.01.040","article-title":"Genetics and genomics of Sjogren's syndrome: research provides clues to pathogenesis and novel therapies","volume":"111","author":"Segal","year":"2011","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.clim.2017.04.003_bb0150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/gene.2009.20","article-title":"Peripheral blood gene expression profiling in Sj\u00f6gren's syndrome","volume":"10","author":"Emamian","year":"2009","journal-title":"Genes Immun."},{"key":"10.1016\/j.clim.2017.04.003_bb0155","doi-asserted-by":"crossref","first-page":"195ra196","DOI":"10.1126\/scitranslmed.3005727","article-title":"NCR3\/NKp30 contributes to pathogenesis in primary Sjogren's syndrome","volume":"5","author":"Rusakiewicz","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.clim.2017.04.003_bb0160","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/gene.2010.64","article-title":"Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseases","volume":"12","author":"Musone","year":"2011","journal-title":"Genes Immun."},{"key":"10.1016\/j.clim.2017.04.003_bb0165","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/BOR.0000000000000310","article-title":"Genetics of systemic lupus erythematosus and Sjogren's syndrome: an update","volume":"28","author":"Teruel","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.clim.2017.04.003_bb0170","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/art.20998","article-title":"Activation of the type I interferon system in primary Sj\u00f6gren's syndrome: a possible etiopathogenic mechanism","volume":"52","author":"B\u00e5ve","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.04.003_bb0175","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/art.21006","article-title":"Gene expression profiling of minor salivary glands clearly distinguishes primary Sj\u00f6gren's syndrome patients from healthy control subjects","volume":"52","author":"Hjelmervik","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.04.003_bb0180","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaut.2009.05.001","article-title":"Gene expression and chromosomal location for susceptibility to Sjogren's syndrome","volume":"33","author":"Perez","year":"2009","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2017.04.003_bb0185","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/art.39204","article-title":"Molecular subsetting of interferon pathways in Sjogren's syndrome","volume":"67","author":"Hall","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.04.003_bb0190","doi-asserted-by":"crossref","first-page":"17609","DOI":"10.1073\/pnas.1209724109","article-title":"Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases","volume":"109","author":"Hall","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2017.04.003_bb0195","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fimmu.2013.00290","article-title":"Interferons in Sj\u00f6gren's syndrome: genes, mechanisms, and effects","volume":"4","author":"Li","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0200","first-page":"1052","article-title":"Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression","volume":"73","author":"Brkic","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.04.003_bb0205","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/annrheumdis-2012-202552","article-title":"MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome","volume":"73","author":"Maria","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.04.003_bb0210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2014.02.008","article-title":"Infection and autoimmunity in Sjogren's syndrome: a clinical study and comprehensive review","volume":"51","author":"Kivity","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2017.04.003_bb0215","doi-asserted-by":"crossref","first-page":"e0164911","DOI":"10.1371\/journal.pone.0164911","article-title":"Correction: association of Sjogren's syndrome in patients with chronic hepatitis virus infection: a population-based analysis","volume":"11","author":"Yeh","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2017.04.003_bb0220","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.38726","article-title":"Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjogren's syndrome","volume":"66","author":"Croia","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.04.003_bb0225","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2249.2004.02704.x","volume":"139","author":"Yamazaki","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0230","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/eji.200839086","article-title":"B-cell-activating factor expressions in salivary epithelial cells after dsRNA virus infection depends on RNA-activated protein kinase activation","volume":"39","author":"Ittah","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0235","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/ar1912","article-title":"B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome","volume":"8","author":"Ittah","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2017.04.003_bb0240","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.4049\/jimmunol.177.10.7391","article-title":"Severe focal sialadenitis and dacryoadenitis in NZM2328 mice induced by MCMV: a novel model for human Sjogren's syndrome","volume":"177","author":"Ohyama","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0245","doi-asserted-by":"crossref","first-page":"12","DOI":"10.20411\/pai.v1i1.72","article-title":"Hepatitis delta virus detected in salivary glands of Sjogren's syndrome patients and recapitulates a Sjogren's syndrome-like phenotype in vivo","volume":"1","author":"Weller","year":"2016","journal-title":"Pathog. Immun."},{"key":"10.1016\/j.clim.2017.04.003_bb0250","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-0714.2012.01181.x","article-title":"Salivary gland hypofunction induced by activation of innate immunity is dependent on type I interferon signaling","volume":"42","author":"Nandula","year":"2013","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.clim.2017.04.003_bb0255","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0714.2008.00700.x","article-title":"Activation of innate immune responses through Toll-like receptor 3 causes a rapid loss of salivary gland function","volume":"38","author":"Deshmukh","year":"2009","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.clim.2017.04.003_bb0260","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1601-0825.2011.01839.x","article-title":"Activation of innate immunity accelerates sialoadenitis in a mouse model for Sj\u00f6gren's syndrome-like disease","volume":"17","author":"Nandula","year":"2011","journal-title":"Oral Dis."},{"key":"10.1016\/j.clim.2017.04.003_bb0265","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/eji.200738008","article-title":"Systemic increase in type I interferon activity in Sj\u00f6gren's syndrome: a putative role for plasmacytoid dendritic cells","volume":"38","author":"Wildenberg","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0270","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.2174\/138920112802273209","article-title":"Ectopic lymphoid neogenesis and lymphoid chemokines in Sjogren's syndrome: at the interplay between chronic inflammation, autoimmunity and lymphomagenesis","volume":"13","author":"Bombardieri","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.clim.2017.04.003_bb0275","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2249.2009.04071.x","article-title":"Decrease of blood dendritic cells and increase of tissue-infiltrating dendritic cells are involved in the induction of Sjogren's syndrome but not in the maintenance","volume":"159","author":"Ozaki","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0280","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/ard.2008.087874","article-title":"Increased frequency of CD16+ monocytes and the presence of activated dendritic cells in salivary glands in primary Sjogren syndrome","volume":"68","author":"Wildenberg","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.04.003_bb0285","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.4049\/jimmunol.179.7.4929","article-title":"Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjogren's syndrome","volume":"179","author":"Bombardieri","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0290","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3109\/14397595.2015.1129694","article-title":"Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjogren's syndrome","volume":"26","author":"Zhao","year":"2016","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.clim.2017.04.003_bb0295","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-3083.2006.01811.x","article-title":"Role of dendritic cells in Sjogren's syndrome","volume":"64","author":"Vogelsang","year":"2006","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0300","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/art.23368","article-title":"Inflammatory stimuli accelerate Sjogren's syndrome-like disease in (NZB x NZW)F1 mice","volume":"58","author":"Deshmukh","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.04.003_bb0305","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/cei.12817","article-title":"Plasmacytoid dendritic cells and type 1 interferon promote peripheral expansion of forkhead box protein 3(+) regulatory T cells specific for the ubiquitous RNA-binding nuclear antigen La\/Sjogren's syndrome (SS)-B","volume":"186","author":"Pan","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0310","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1601-0825.2011.01852.x","article-title":"Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjogren's syndrome","volume":"18","author":"Roescher","year":"2012","journal-title":"Oral Dis."},{"key":"10.1016\/j.clim.2017.04.003_bb0315","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1002\/art.23073","volume":"56","author":"Manoussakis","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.04.003_bb0320","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1189\/jlb.0113036","article-title":"CXCL13 is elevated in Sjogren's syndrome in mice and humans and is implicated in disease pathogenesis","volume":"94","author":"Kramer","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.clim.2017.04.003_bb0325","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1002\/art.30465","article-title":"Chitinases in the salivary glands and circulation of patients with Sjogren's syndrome: macrophage harbingers of disease severity","volume":"63","author":"Greenwell-Wild","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.04.003_bb0330","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ajpath.2012.05.014","article-title":"Critical involvement of macrophage infiltration in the development of Sj\u00f6gren's syndrome-associated dry eye","volume":"181","author":"Zhou","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.clim.2017.04.003_bb0335","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4049\/jimmunol.179.1.26","article-title":"Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages","volume":"179","author":"Kong","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0340","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.4049\/jimmunol.176.10.6277","article-title":"The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death","volume":"176","author":"Espinosa","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0345","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1007\/s00018-016-2260-8","article-title":"Adherens Junction and E-Cadherin complex regulation by epithelial polarity","volume":"73","author":"Coopman","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.clim.2017.04.003_bb0350","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2013.02.001","article-title":"Sjogren's syndrome and the epithelial target: a comprehensive review","volume":"42","author":"Barrera","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2017.04.003_bb0355","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.semcdb.2014.08.011","article-title":"Architecture of tight junctions and principles of molecular composition","volume":"36","author":"Van Itallie","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.clim.2017.04.003_bb0360","doi-asserted-by":"crossref","first-page":"C1191","DOI":"10.1152\/ajpcell.00144.2008","article-title":"Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma alter tight junction structure and function in the rat parotid gland Par-C10 cell line","volume":"295","author":"Baker","year":"2008","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.clim.2017.04.003_bb0365","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/art.27362","article-title":"Disruption of tight junction structure in salivary glands from Sjogren's syndrome patients is linked to proinflammatory cytokine exposure","volume":"62","author":"Ewert","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.04.003_bb0370","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1189\/jlb.2MR0416-201R","article-title":"Cell-autonomous stress responses in innate immunity","volume":"101","author":"Moretti","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.clim.2017.04.003_bb0375","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaut.2010.06.011","article-title":"The role of intrinsic epithelial activation in the pathogenesis of Sjogren's syndrome","volume":"35","author":"Manoussakis","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2017.04.003_bb0380","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/art.30381","article-title":"Associations between salivary gland histopathologic diagnoses and phenotypic features of Sj\u00f6gren's syndrome among 1,726 registry participants","volume":"63","author":"Daniels","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.04.003_bb0385","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2249.2006.03311.x","article-title":"Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sj\u00f6gren's syndrome","volume":"147","author":"Spachidou","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0390","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.coi.2004.11.001","article-title":"NK cells in innate immunity","volume":"17","author":"Hamerman","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0395","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/icb.2013.99","article-title":"TLR-mediated activation of NK cells and their role in bacterial\/viral immune responses in mammals","volume":"92","author":"Adib-Conquy","year":"2014","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.clim.2017.04.003_bb0400","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.immuni.2014.09.013","article-title":"TRAIL+ NK cells control CD4+ T cell responses during chronic viral infection to limit autoimmunity","volume":"41","author":"Schuster","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2017.04.003_bb0405","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.lab.2006.01.001","article-title":"Characterization of peripheral natural killer cells in primary Sjogren's syndrome: impaired NK cell activity and low NK cell number","volume":"147","author":"Izumi","year":"2006","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.clim.2017.04.003_bb0410","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/1744666X.2016.1109449","article-title":"Early diagnosis of primary Sjogren's syndrome: EULAR-SS task force clinical recommendations","volume":"12","author":"Brito-Zeron","year":"2016","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0415","first-page":"1019","article-title":"Toll-like receptor in salivary glands from patients with Sj\u00f6gren's syndrome: functional analysis by human salivary gland cell line","volume":"34","author":"Kawakami","year":"2007","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2017.04.003_bb0420","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jaut.2010.06.010","article-title":"Salivary epithelial cells from Sjogren's syndrome patients are highly sensitive to anoikis induced by TLR-3 ligation","volume":"35","author":"Manoussakis","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2017.04.003_bb0425","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/ar3780","article-title":"TLR2 ligation induces the production of IL-23\/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome","volume":"14","author":"Kwok","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2017.04.003_bb0430","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1600-0714.2012.01136.x","article-title":"Involvement of toll-like receptors in autoimmune sialoadenitis of the non-obese diabetic mouse","volume":"41","author":"Shimizu","year":"2012","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.clim.2017.04.003_bb0435","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.tripleo.2010.01.006","article-title":"Expression of Toll-like receptors 7, 8, and 9 in primary Sj\u00f6gren's syndrome","volume":"109","author":"Zheng","year":"2010","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.clim.2017.04.003_bb0440","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12016-013-8402-y","article-title":"TLR2 and TLR4 in autoimmune diseases: a comprehensive review","volume":"47","author":"Liu","year":"2014","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.25242","article-title":"Check your cultures! A list of cross-contaminated or misidentified cell lines","volume":"127","author":"Capes-Davis","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.clim.2017.04.003_bb0450","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/BF02624009","article-title":"Beta-adrenergic responsiveness in a human submandibular tumor cell line (A253)","volume":"25","author":"Marmary","year":"1989","journal-title":"In Vitro Cell. Dev. Biol."},{"key":"10.1016\/j.clim.2017.04.003_bb0455","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/rheumatology\/37.7.779","article-title":"Chemokine expression and leucocyte infiltration in Sjogren's syndrome","volume":"37","author":"Cuello","year":"1998","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.clim.2017.04.003_bb0460","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/rheumatology\/keq079","article-title":"Regulation of disease susceptibility and mononuclear cell infiltration into the labial salivary glands of Sjogren's syndrome by monocyte chemotactic protein-1","volume":"49","author":"Iwamoto","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2017.04.003_bb0465","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.clim.2005.06.016","article-title":"Distinct profiles of Sj\u00f6gren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF","volume":"117","author":"Szodoray","year":"2005","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0470","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1601-0825.2009.01582.x","article-title":"Cytokines in Sjogren's syndrome","volume":"15","author":"Roescher","year":"2009","journal-title":"Oral Dis."},{"key":"10.1016\/j.clim.2017.04.003_bb0475","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2174\/138945009789735101","article-title":"Targeting Toll-like receptors in autoimmunity","volume":"10","author":"Midwood","year":"2009","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.clim.2017.04.003_bb0480","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00296-012-2381-9","article-title":"TLR3-mediated apoptosis and activation of phosphorylated Akt in the salivary gland epithelial cells of primary Sj\u00f6gren's syndrome patients","volume":"33","author":"Nakamura","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.clim.2017.04.003_bb0485","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/eji.200738013","article-title":"Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways","volume":"38","author":"Ittah","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0490","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","article-title":"American College of Rheumatology classification criteria for Sj\u00f6gren's syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren's International Collaborative Clinical Alliance cohort","volume":"64","author":"Shiboski","year":"2012","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.clim.2017.04.003_bb0495","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/cei.12432","article-title":"Toll-like receptor 3 stimulation promotes Ro52\/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway","volume":"178","author":"Kyriakidis","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0500","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.immuni.2004.05.010","article-title":"Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches","volume":"20","author":"Thien","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2017.04.003_bb0505","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1074-7613(04)00079-2","article-title":"Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF","volume":"20","author":"Lesley","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2017.04.003_bb0510","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI0214121","article-title":"Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sj\u00f6gren's syndrome","volume":"109","author":"Groom","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2017.04.003_bb0515","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.autrev.2010.05.006","article-title":"B-cell tolerance breakdown in Sjogren's syndrome: focus on BAFF","volume":"9","author":"Varin","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2017.04.003_bb0520","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bjh.13192","article-title":"Sjogren syndrome-associated lymphomas: an update on pathogenesis and management","volume":"168","author":"Nocturne","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clim.2017.04.003_bb0525","doi-asserted-by":"crossref","first-page":"e0120383","DOI":"10.1371\/journal.pone.0120383","article-title":"Expression of Toll-like receptor -7 and -9 in B cell subsets from patients with primary Sjogren's syndrome","volume":"10","author":"Karlsen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2017.04.003_bb0530","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/sji.12368","article-title":"TLR-7 and -9 stimulation of peripheral blood B cells indicate altered TLR Signalling in primary Sjogren's syndrome patients by increased secretion of cytokines","volume":"82","author":"Karlsen","year":"2015","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0535","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/annrheumdis-2016-209589","article-title":"Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjogren's syndrome","volume":"76","author":"Maria","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.04.003_bb0540","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/672395","article-title":"DAMPening inflammation by modulating TLR signalling","volume":"2010","author":"Piccinini","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.clim.2017.04.003_bb0545","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nri2873","article-title":"Sterile inflammation: sensing and reacting to damage","volume":"10","author":"Chen","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0550","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cyto.2014.02.009","article-title":"Early events in Sjogren's syndrome pathogenesis: The importance of innate immunity in disease initiation","volume":"67","author":"Kramer","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.clim.2017.04.003_bb0555","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/labinvest.2013.114","article-title":"The Hippo signaling pathway is required for salivary gland development and its dysregulation is associated with Sjogren's syndrome","volume":"93","author":"Enger","year":"2013","journal-title":"Lab. Investig."},{"key":"10.1016\/j.clim.2017.04.003_bb0560","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1002\/art.20730","article-title":"Segment-specific but pathologic laminin isoform profiles in human labial salivary glands of patients with Sjogren's syndrome","volume":"50","author":"Laine","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.04.003_bb0565","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.chom.2008.08.007","article-title":"The caspase-1 inflammasome: a pilot of innate immune responses","volume":"4","author":"Yu","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.clim.2017.04.003_bb0570","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1002\/eji.200737871","article-title":"Orchestration of pathogen recognition by inflammasome diversity: variations on a common theme","volume":"37","author":"Martinon","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0575","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-cellbio-101011-155745","article-title":"Inflammasomes and their roles in health and disease","volume":"28","author":"Lamkanfi","year":"2012","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.clim.2017.04.003_bb0580","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/joim.12115","article-title":"The P2X7 receptor-inflammasome complex has a role in modulating the inflammatory response in primary Sj\u00f6gren's syndrome","volume":"274","author":"Baldini","year":"2013","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.clim.2017.04.003_bb0585","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/icb.2008.70","article-title":"Inflammatory caspases are critical for enhanced cell death in the target tissue of Sj\u00f6gren's syndrome before disease onset","volume":"87","author":"Bulosan","year":"2009","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.clim.2017.04.003_bb0590","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1517\/14728222.2013.754427","article-title":"Targeting IL-1 in Sj\u00f6gren's syndrome","volume":"17","author":"Yamada","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.clim.2017.04.003_bb0595","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.4049\/jimmunol.181.4.2898","article-title":"Identification of IL-18 and Th17 cells in salivary glands of patients with Sj\u00f6gren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18","volume":"181","author":"Sakai","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0600","doi-asserted-by":"crossref","first-page":"R447","DOI":"10.1186\/ar1209","article-title":"Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjogren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate","volume":"6","author":"Bombardieri","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2017.04.003_bb0605","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/ar2375","article-title":"Biomarker profiles in serum and saliva of experimental Sjogren's syndrome: associations with specific autoimmune manifestations","volume":"10","author":"Delaleu","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2017.04.003_bb0610","doi-asserted-by":"crossref","first-page":"C790","DOI":"10.1152\/ajpcell.00072.2012","article-title":"P2X7 receptor activation induces inflammatory responses in salivary gland epithelium","volume":"303","author":"Woods","year":"2012","journal-title":"Am. J. Phys. Cell Physiol."},{"key":"10.1016\/j.clim.2017.04.003_bb0615","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.it.2014.07.005","article-title":"Long non-coding RNAs in the regulation of the immune response","volume":"35","author":"Heward","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0620","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.coi.2013.12.001","article-title":"Long noncoding RNAs in innate and adaptive immunity","volume":"26","author":"Fitzgerald","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0625","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2009.02.006","article-title":"Evolution and functions of long noncoding RNAs","volume":"136","author":"Ponting","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.clim.2017.04.003_bb0630","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","article-title":"Molecular mechanisms of long noncoding RNAs","volume":"43","author":"Wang","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.clim.2017.04.003_bb0635","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.trsl.2016.10.001","article-title":"Noncoding RNAs in the development, diagnosis, and prognosis of colorectal cancer","volume":"181","author":"Weng","year":"2017","journal-title":"Transl. Res."},{"key":"10.1016\/j.clim.2017.04.003_bb0640","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaut.2016.06.020","article-title":"The critical role of epigenetics in systemic lupus erythematosus and autoimmunity","volume":"74","author":"Long","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2017.04.003_bb0645","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/1756-185X.12752","article-title":"Long noncoding RNAs could be potential key players in the pathophysiology of Sjogren's syndrome","volume":"18","author":"Sandhya","year":"2015","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.04.003_bb0650","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13075-016-1005-2","article-title":"Long non-coding RNA expression profile in minor salivary gland of primary Sjogren's syndrome","volume":"18","author":"Shi","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2017.04.003_bb0655","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17101712","article-title":"MicroRNA in control of gene expression: an overview of nuclear functions","volume":"17","author":"Catalanotto","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2017.04.003_bb0660","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.autrev.2013.07.003","article-title":"The role of miRNA in inflammation and autoimmunity","volume":"12","author":"Singh","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2017.04.003_bb0665","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/ar4131","article-title":"MicroRNA control in the development of systemic autoimmunity","volume":"15","author":"Hu","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2017.04.003_bb0670","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/art.30131","article-title":"MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjogren's syndrome","volume":"63","author":"Alevizos","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.04.003_bb0675","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1601-0825.2011.01849.x","article-title":"Deep sequencing of short RNAs reveals novel microRNAs in minor salivary glands of patients with Sjogren's syndrome","volume":"18","author":"Tandon","year":"2012","journal-title":"Oral Dis."},{"key":"10.1016\/j.clim.2017.04.003_bb0680","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.autrev.2016.09.003","article-title":"The role of microRNAs in the pathogenesis of autoimmune diseases","volume":"15","author":"Chen","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2017.04.003_bb0685","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/eji.201040757","article-title":"Altered miR-146a expression in Sjogren's syndrome and its functional role in innate immunity","volume":"41","author":"Pauley","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0690","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/cei.12664","article-title":"Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro\/SSA and La\/SSB in primary Sjogren's syndrome","volume":"182","author":"Gourzi","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0695","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.imlet.2011.09.006","article-title":"Increased microRNA-146a\/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjogren's syndrome","volume":"141","author":"Zilahi","year":"2012","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.clim.2017.04.003_bb0700","article-title":"Simultaneously increased expression of microRNA-155 and suppressor of cytokine signaling 1 (SOCS1) gene in the peripheral blood mononuclear cells of patients with primary Sjogren's syndrome","author":"Chen","year":"2015","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.04.003_bb0705","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/jop.12187","article-title":"miR-146a and miR-155 expression in PBMCs from patients with Sjogren's syndrome","volume":"43","author":"Shi","year":"2014","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.clim.2017.04.003_bb0710","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13075-016-0987-0","article-title":"Sjogren's syndrome-associated microRNAs in CD14(+) monocytes unveils targeted TGFbeta signaling","volume":"18","author":"Williams","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2017.04.003_bb0715","doi-asserted-by":"crossref","first-page":"e84634","DOI":"10.1371\/journal.pone.0084634","article-title":"Suppression of molecular inflammatory pathways by toll-like receptor 7, 8, and 9 antagonists in a model of IL-23-induced skin inflammation","volume":"8","author":"Suarez-Farinas","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2017.04.003_bb0720","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/01.MIB.0000172807.26748.16","article-title":"RDP58 is a novel and potentially effective oral therapy for ulcerative colitis","volume":"11","author":"Travis","year":"2005","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.clim.2017.04.003_bb0725","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.pharmthera.2013.03.003","article-title":"Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases","volume":"138","author":"Li","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.clim.2017.04.003_bb0730","unstructured":"ClinicalTrials.gov. National Library of Medicine\/ National Institutes of Health, 1 Feb. 2000. Web. 04 Apr. 2017."},{"key":"10.1016\/j.clim.2017.04.003_bb0735","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/art.22303","article-title":"Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis","volume":"56","author":"Izmailova","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.04.003_bb0740","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/jpet.108.143800","article-title":"A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models","volume":"329","author":"Mbalaviele","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.clim.2017.04.003_bb0745","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/rheumatology\/keq226","article-title":"Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients","volume":"49","author":"Capolunghi","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2017.04.003_bb0750","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/1352458508099141","article-title":"Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosis","volume":"15","author":"Broadley","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.clim.2017.04.003_bb0755","doi-asserted-by":"crossref","first-page":"e87712","DOI":"10.1371\/journal.pone.0087712","article-title":"Targeting innate receptors with MIS416 reshapes Th responses and suppresses CNS disease in a mouse model of multiple sclerosis","volume":"9","author":"White","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2017.04.003_bb0760","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.rdc.2016.03.001","article-title":"Use of biologics in Sjogren's syndrome","volume":"42","author":"Nocturne","year":"2016","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.clim.2017.04.003_bb0765","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kev257","article-title":"Efficacy and safety of belimumab given for 12 months in primary Sjogren's syndrome: the BELISS open-label phase II study","author":"De Vita","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2017.04.003_bb0770","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/annrheumdis-2013-203991","article-title":"Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study","volume":"74","author":"Mariette","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.04.003_bb0775","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev-med-043015-123313","article-title":"Mechanisms and new strategies for primary Sjogren's syndrome","volume":"68","author":"Mavragani","year":"2017","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.clim.2017.04.003_bb0780","doi-asserted-by":"crossref","first-page":"e30123","DOI":"10.1371\/journal.pone.0030123","article-title":"Interleukin-1 inhibition and fatigue in primary Sjogren's syndrome\u2013a double blind, randomised clinical trial","volume":"7","author":"Norheim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2017.04.003_bb0785","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/cpdd.193","article-title":"Safety, bioavailability, and pharmacokinetics of VGX-1027-a novel oral anti-inflammatory drug in healthy human subjects","volume":"5","author":"Lee","year":"2016","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.clim.2017.04.003_bb0790","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/imm.12267","article-title":"VGX-1027 modulates genes involved in lipopolysaccharide-induced Toll-like receptor 4 activation and in a murine model of systemic lupus erythematosus","volume":"142","author":"Fagone","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2017.04.003_bb0795","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.rdc.2016.03.010","article-title":"New treatment guidelines for Sjogren's disease","volume":"42","author":"Vivino","year":"2016","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.clim.2017.04.003_bb0800","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2017.04.003_bb0805","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/hum.2010.069","article-title":"Alpha-galactosidase A expressed in the salivary glands partially corrects organ biochemical deficits in the fabry mouse through endocrine trafficking","volume":"22","author":"Passineau","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.clim.2017.04.003_bb0810","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13075-015-0714-2","article-title":"IL-17 sequestration via salivary gland gene therapy in a mouse model of Sjogren's syndrome suppresses disease-associated expression of the putative autoantigen Klk1b22","volume":"17","author":"Wu","year":"2015","journal-title":"Arthritis Res. Ther."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616306544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616306544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T13:47:09Z","timestamp":1719150429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661616306544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":162,"alternative-id":["S1521661616306544"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2017.04.003","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innate immunity in Sj\u00f6gren's syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2017.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}